Antirheumatic Agents

"Antirheumatic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Drugs that are used to treat RHEUMATOID ARTHRITIS.

Descriptor ID	D018501
MeSH Number(s)	D27.505.954.329
Concept/Terms	Antirheumatic Agents Antirheumatic Agents Anti-Rheumatic Drugs Anti Rheumatic Drugs Antirheumatic Drugs Anti-Rheumatic Agents Anti Rheumatic Agents Antirheumatic Drugs, Disease-Modifying Antirheumatic Drugs, Disease-Modifying Antirheumatic Drugs, Disease Modifying DMARD Disease-Modifying, Antirheumatic Second-Line Drugs Disease Modifying, Antirheumatic Second Line Drugs Antirheumatic Disease-Modifying Second-Line Drugs Antirheumatic Disease Modifying Second Line Drugs Disease-Modifying Antirheumatic Drugs Disease Modifying Antirheumatic Drugs Anti-Rheumatic Agents, Non-Steroidal Anti-Rheumatic Agents, Non-Steroidal Anti Rheumatic Agents, Non Steroidal Non-Steroidal Anti-Rheumatic Agents

Below are MeSH descriptors whose meaning is more general than "Antirheumatic Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Antirheumatic Agents [D27.505.954.329]

Below are MeSH descriptors whose meaning is more specific than "Antirheumatic Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Antirheumatic Agents" by people in this website by year, and whether "Antirheumatic Agents" was a major or minor topic of these publications.

Bar chart showing 26 publications over 15 distinct years, with a maximum of 3 publications in 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2004	1	0	1
2005	2	0	2
2006	1	1	2
2007	1	1	2
2009	1	0	1
2010	1	1	2
2012	2	0	2
2014	0	2	2
2015	0	1	1
2016	2	0	2
2018	1	0	1
2020	1	1	2
2021	3	0	3
2022	1	0	1
2023	2	0	2

Below are the most recent publications written about "Antirheumatic Agents" by people in Profiles.

Amaral JK, Bingham CO, Taylor PC, Vil? LM, Weinblatt ME, Schoen RT. Therapy for Chikungunya Arthritis: A Study of 133 Brazilian Patients. Am J Trop Med Hyg. 2023 09 06; 109(3):542-547.

View in: PubMed
Mehta P, Situ BA, Wise LM, Savvas S, Daskivich LP, Toy BC. Mitigating Hydroxychloroquine Toxicity with a Clinical Decision Support Tool. Ophthalmology. 2023 08; 130(8):874-876.

View in: PubMed
Fortuna G, Whitmire S, Sullivan K, Alajbeg I, Andabak-Rogulj A, Pedersen AML, Vissink A, di Fede O, Aria M, Jager DJ, Noll J, Jensen SB, Wolff A, Brennan MT. Impact of medications on salivary flow rate in patients with xerostomia: a retrospective study by the Xeromeds Consortium. Clin Oral Investig. 2023 Jan; 27(1):235-248.

View in: PubMed
Zheng C, Fillmore NR, Ramos-Cejudo J, Brophy M, Osorio R, Gurney ME, Qiu WQ, Au R, Perry G, Dubreuil M, Chen SG, Qi X, Davis PB, Do N, Xu R. Potential long-term effect of tumor necrosis factor inhibitors on dementia risk: A propensity score matched retrospective cohort study in US veterans. Alzheimers Dement. 2022 06; 18(6):1248-1259.

View in: PubMed
Jolly M, Sehgal V, Arora S, Azizoddin D, Pinto B, Sharma A, Devilliers H, Inoue M, Toloza S, Bertoli A, Blazevic I, Vil? LM, Moldovan I, Torralba KD, Mazzoni D, Cicognani E, Hasni S, Goker B, Haznedaroglu S, Bourre-Tessier J, Navarra SV, Clarke A, Weisman M, Wallace D, Mok CC. Does hydroxychloroquine improve patient reported outcomes in patients with lupus? Lupus. 2021 Oct; 30(11):1790-1798.

View in: PubMed
Medina-Cintr?n N, Mart?nez I, P?rez-R?os N, Berr?os-L?pez Y, Vil? LM. Clinical Manifestations and Outcomes in Disease-Modifying Antirheumatic Drug-Naive Adult Patients with Chronic Chikungunya Arthritis. Am J Trop Med Hyg. 2021 03 08; 104(5):1741-1746.

View in: PubMed
Mitchell BI, Laws EI, Chow DC, SahBandar IN, Gangcuangco LMA, Shikuma CM, Ndhlovu LC. Increased Monocyte Inflammatory Responses to Oxidized LDL Are Associated with Insulin Resistance in HIV-Infected Individuals on Suppressive Antiretroviral Therapy. Viruses. 2020 10 05; 12(10).

View in: PubMed
V?zquez-Otero I, Medina-Cintr?n N, Arroyo-?vila M, Gonz?lez-Sep?lveda L, Vil? LM. Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus. Lupus Sci Med. 2020 05; 7(1).

View in: PubMed
Elion RA, Althoff KN, Zhang J, Moore RD, Gange SJ, Kitahata MM, Crane HM, Drozd DR, Stein JH, Klein MB, Eron JJ, Silverberg MJ, Mathews WC, Justice AC, Sterling TR, Rabkin CS, Mayor AM, Klein DB, Horberg MA, Bosch RJ, Eyawo O, Palella FJ. Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV. J Acquir Immune Defic Syndr. 2018 05 01; 78(1):62-72.

View in: PubMed
Huber AM, Kim S, Reed AM, Carrasco R, Feldman BM, Hong SD, Kahn P, Rahimi H, Robinson AB, Vehe RK, Weiss JE, Spencer C. Childhood Arthritis and Rheumatology Research Alliance Consensus Clinical Treatment Plans for Juvenile Dermatomyositis with Persistent Skin Rash. J Rheumatol. 2017 01; 44(1):110-116.

View in: PubMed

People

Explore

Similar Concepts

Top Journals